CH
VEA icon

CVS Health’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

CVS Health’s Portfolio VEA Stock Details VEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,000
Closed -$1.28M – 29
2026
Q1 		$1.28M Buy
+20,000
New +$1.32M 0.6% 19

Other funds holding VEA

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Betterment LLC
Betterment LLC New York $59.1B AUM 18.41% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
Wealthfront Advisers
Wealthfront Advisers Palo Alto, California $52B AUM 24.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CVS Health's VEA Position: Q2 2026 in Review

CVS Health sold out of Vanguard FTSE Developed Markets ETF (VEA) in Q2 2026, closing a stake of 20,000 shares — an estimated $1.28M sold.

CVS Health first reported a position in VEA in Q1 2026 and held it in 1 quarter. The position peaked at $1.28M in Q1 2026. 3,011 funds tracked by Wall St. Rank hold VEA as of Q2 2026.

  • CVS Health reported no remaining Vanguard FTSE Developed Markets ETF position as of Q2 2026 after selling out during the quarter.
  • CVS Health sold 20,000 Vanguard FTSE Developed Markets ETF shares in Q2 2026, an estimated $1.28M.
  • CVS Health first reported a position in Vanguard FTSE Developed Markets ETF in Q1 2026 and held it in 1 quarter.
  • CVS Health's Vanguard FTSE Developed Markets ETF position peaked at $1.28M in Q1 2026.
  • 3,011 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q2 2026.

Based on CVS Health's 13F filing for Q2 2026, filed 6 Aug 2026.